Sort
21,281 grants matching “influenza”
Lung leukocytes promote alveolar epithelial regeneration after severe injury
$635,891Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2020 · HL
Intersection of Severe Respiratory Infection and Viral Latency
$635,732Ashley Steed · Washington University · R01 · FY2024 · AI
Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
$635,564Diana Sm Buist · Kaiser Foundation Research Institute · R01 · FY2020 · CA
A Disease-Modifying Protein Therapeutic for the Treatment of COPD
$635,475Christopher Lucas Prince · Verra Therapeutics, Inc. · R44 · FY2024 · HL
Fusion: Vaccine conjugate technology to advance vaccine safety and efficacy
$635,274David Jay Burkhart · University Of Montana · R01 · FY2020 · AI
Stress and the Genome: Testing the Impact of Social Effects on Gene Regulation
$635,182Jenny Tung · Duke University · R01 · FY2018 · AG
Targeting integrin outside-in signaling for treating sepsis
$634,951Randal A Skidgel · Dupage Medical Technology, Inc. · R44 · FY2022 · HL
Functional diversity of lung pericytes in lung injury
$634,838Chi F Hung · University Of Washington · R01 · FY2023 · HL
Angiopoietin/Tie signaling regulation of vascular leakage in lung inflammation
$634,697Donald M McDonald · University Of California, San Francisco · R01 · FY2021 · HL
Deciphering the Heterogeneous Response to Influenza by a Multi-Scale Systems Approach
$634,480Christian Forst · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine)
$634,471Duane A. Mitchell · University Of Florida · R01 · FY2015 · CA
Genome-wide association to Staphylococcus carriage
$634,435Eric L Brown · University Of Texas Hlth Sci Ctr Houston · R01 · FY2010 · AI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
$634,403Gayani Tillekeratne · Duke University · R01 · FY2022 · AI
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
$634,369Jianwen Que · Columbia University Health Sciences · R01 · FY2021 · HL
Angiopoietin/Tie signaling regulation of vascular leakage in lung inflammation
$634,369Donald M McDonald · University Of California, San Francisco · R01 · FY2020 · HL
Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogens
$634,314Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2023 · AI
Containing Bioterroist and Emerging Infectious Diseases
$634,266Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2008 · GM
Adjuvant Delivery by PRINT Nanoparticles
$634,201Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2016 · AI
Analysis of Historical Influenza Viruses
$634,168Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Influenza Viral Genomics and Evolution
$634,168Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Unraveling Human T Follicular Helper Cell Development
$634,142Philip A Mudd · Washington University · R01 · FY2025 · AI
H. influenzae: Role of Sialic Acid in Virulence
$634,104Michael A. Apicella · University Of Iowa · R01 · FY2011 · AI
Novel biofilm polymicrobial infection-resistant implants for otologic application
$634,028Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2009 · DC
Intervention Strategies for Non-Folate Responsive Neural Tube Defects
$634,011Richard H. Finnell · Baylor College Of Medicine · R01 · FY2023 · HD
Intervention Strategies for Non-Folate Responsive Neural Tube Defects
$634,011Richard H. Finnell · Baylor College Of Medicine · R01 · FY2022 · HD